Apex Biotechnology Revenue

In the year 2024, Apex Biotechnology had annual revenue of 1.85B TWD with 10.48% growth. Apex Biotechnology had revenue of 454.00M in the quarter ending December 31, 2024, with 10.67% growth.

Revenue

1.85B

Revenue Growth

+10.48%

P/S Ratio

1.72

Revenue / Employee

n/a

Employees

n/a

Market Cap

3.19B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.85B	175.67M	10.48%
Dec 31, 2023	1.68B	-567.64M	-25.29%
Dec 31, 2022	2.24B	112.52M	5.28%
Dec 31, 2021	2.13B	126.32M	6.30%
Dec 31, 2020	2.01B	-193.53M	-8.80%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	9.73B
Caliway Biopharmaceuticals	44.43M
Bora Pharmaceuticals Co., LTD.	19.25B
Lotus Pharmaceutical	18.58B
Oneness Biotech	117.93M
Polaris Group	107.00M
Lumosa Therapeutics	39.15M
Pegavision	6.82B

Revenue Rankings